Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B‐cell lymphoma
Authors:
Open Access
- 11 November 2008
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 84 (2) , 93-97
Abstract
Peripheral blood absolute lymphocyte count (ALC) is a survival prognostic factor in hematological malignancies. No reports have addressed whether ALC at the time of first relapse (ALC‐R) predicts survival. Thus, we assessed the prognostic significance of ALC‐R in diffuse large B‐cell lymphoma (DLBCL). Patients were required to have been diagnosed with first relapsed DLBCL, have ALC‐R values, and to be followed at Mayo Clinic, Rochester. From Feb 1987 until March 2006, 97 first relapsed DLBCL patients qualified for the study. The overall survival (OS) and progression‐free survival (PFS) were measured from the time of first relapse. The value of ALC‐R≥ 1.0 × 109/L was used for the analysis. Both groups (ALC‐R ≥ 1 or < 1 × 109/L) were balanced for the international prognostic index at relapse (IPI‐R) (P= 0.3), and for autologous stem cell transplantation (P= 0.4). Superior OS and PFS were observed with an ALC‐R ≥ 1.0 × 109/L (N= 60) versus ALC‐R < 1.0 × 109/L (N= 37) [median OS: 28.7 months, 5 years OS rates of 39% versus median OS: 10.2 months, 5 years OS rates of 14%,P< 0.002; and median PFS: 14.8 months, 5 years PFS rates of 21% versus median PFS: 6.5 months, 5 years PFS rates of 8%,P< 0.004, respectively]. ALC‐R was an independent prognostic factor for OS [RR = 0.4,P< 0.01] and PFS [RR = 0.5,P< 0.005]. ALC‐R predicts survival suggesting that host immunity is an important variable predicting survival in first relapsed DLBCL. Am. J. Hematol. 2009.Keywords
This publication has 17 references indexed in Scilit:
- Prognostic importance of T and NK‐cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemiaBritish Journal of Haematology, 2008
- Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell LymphomaTransplantation and Cellular Therapy, 2008
- Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphomaLeukemia & Lymphoma, 2008
- Lymphocytopenia as a prognostic marker for diffuse large B cell lymphomasLeukemia & Lymphoma, 2008
- Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphomaLeukemia, 2007
- Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomasBritish Journal of Haematology, 2007
- The International Prognostic Index Assessed at Relapse Predicts Outcomes of Autologous Transplantation for Diffuse Large-Cell Non-Hodgkin’s Lymphoma in Second Complete or Partial RemissionTransplantation and Cellular Therapy, 2007
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantationLeukemia & Lymphoma, 2005
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958